Skip to main content

COVID 19 Updates from RheumNow

Social

wonder if vit D is a surrogate for poor health, low SES, diet? In #SARSCoV2 infection low vit D has worse outcomes but clusters racially (⬇️ by skin tone) & seems related to SES. But perhaps adding vit D can help immune system & be anti-inflammatory #EULAR2021 @RheumNow POS0100 https://t.co/TEf52bLs0i
2 years 10 months ago
Zara Izadi presents @rheum_covid data on machine learning algorithms to predict ARDS in RMD patients with COVID. Gradient boosting machine had 81% sensitivity to predict ARDS from baseline data @RheumNow #EULAR2021 Abstr#OP0288 https://t.co/tHlPzeX9He
Richard Conway @RichardPAConway ( View Tweet )
2 years 10 months ago
Poorer outcomes with #JAKi in pts who get #SARSCoV2 but ? related to line of therapy - worse off if 2nd line advanced Rx in RA vs 1st line? JAKi has short half life so it washes out? And..#baricitinib added to #remdesivir improves outcomes NEJM @RheumNow #EULAR2021 #OP0006 Dunno! https://t.co/583z6Mlw3y
2 years 10 months ago
Presentation 3480 at #EULAR2021. Your patient is on CellCept, has negative COVID spike IgG and IgM antibodies after vaccination with mRNA vaccination x2. What do you counsel on this test? @RheumNow

Eric Dein @ejdein1 ( View Tweet )

2 years 10 months ago
#Digital #rheumatology in the era of #COVID-19: evidently increasing inclination of patients and physicians to use digital health apps for recording data- as informed by a national survey by @JK77775 and colleagues #EULAR2021 @ARD_BMJ https://t.co/Uo60qZurhG
2 years 10 months ago
Our SLR on pathogenesis of SARS-CoV-2 Main findings: TH1 cytokines and IL-6 associated w/ severe COVID19 and fatal outcomes. ⬆️ classical blood monocytes and polyfunctional T cells. Impaired IFN response associated w/ poor outcomes. #POS0052 @Rheumnow #EULAR2021 @alessia_alunno https://t.co/PGph5IRBkX
Aurelie Najm @AurelieRheumo ( View Tweet )
2 years 10 months ago
Novel Results from the @rheum_covid register in #RA patients presented by @jeffsparks #OP0006 Higher risk for patients on rituximab or on JAK inhibitors for hospitalisation & ventilation or death after #COVID19 infection compared to TNFi users. #EULAR2021 @RheumNow https://t.co/40h5zVpxAO
Paul Studenic @Stiddyo ( View Tweet )
2 years 10 months ago
Result from the #EULAR2021 recommendations on management of RMD in COVID update SLR: No evidence that people with RMDs present an increased risk of contracting COVID19, consistent with the initial Recos. @RheumNow https://t.co/2Q0s3ZKJOP
Aurelie Najm @AurelieRheumo ( View Tweet )
2 years 10 months ago
⁦@jeffsparks⁩ knocking it out of the park presenting our findings on b/tsDMARD associations with COVID-19 outcomes ⁦@eular_org⁩ ⁦@EULAR_Press⁩ check out our full paper just published in ⁦@ARD_BMJ⁩ https://t.co/jcA1LN45R3
2 years 10 months ago
Abs#OP0009 presents 8 min web-based video for COVID vax education sent via text message. 76% more likely to get vax. #EULAR2021. @RheumNow. Pts need to hear from their rheumatologists our thoughts on vax, ideally in person, but phone is great outreach https://t.co/aimGBufYpe
Eric Dein @ejdein1 ( View Tweet )
2 years 10 months ago